Mouse embryonic stem cells have been shown to differentiate into a variety
of tissues in vitro and in transplantation experiments can produce many dif
ferent cell types. Multipotent stem cells in adult humans have also shown a
high degree of plasticity: haemopoietic stem cells, for example, have been
shown to contribute to several other tissues, such as liver. From these si
mple observations there has been considerable extrapolation into the use of
such putative totipotent stem cells in the clinical setting, with the deve
lopment of 'designer' tissue engineering, whose aim is to create large tiss
ues or even whole organs for clinical use. In practical terms, however, the
re are many limitations and difficulties and clinical use has been restrict
ed to a very few settings, eg the use of fetal cells in Parkinson's disease
. Nonetheless, there is enormous potential in this area, and also in the ap
plication of embryonic or adult stem cells as carriers for gene therapy; bu
t the limitations of such treatment, in particular the stability of manipul
ated cells, and the problems of ageing and Ooncogenicity, not to mention a
host of ethical and regulatory issues, all need to be considered.